← Home / IMMUNITYBIO, INC. (IBRX)
Stock Analysis
IMMUNITYBIO, INC. (IBRX)
IBRX
IBRX · Healthcare • Biotech
7.45 +9.08%
Track IBRX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IBRX price is:
52W Range Position
57%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-31 11:44 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 7.69. Holding above 6.37 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
6.37
↗
Break Above
Confirmation improves above resistance.
7.69
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 6.37
Recent Company Events
SEC VERIFIED
Latest material filings
MAY
18
◈
Strategic Agreement
HIGH
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to
(NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced an exclusive U.S.
8-K Filing • SEC EDGAR
MAY
7
●
Financial Results
HIGH
ImmunityBio Reports Record Q1 2026 Results: Net Product Revenue
Increased Nearly 2.7x Year-Over-Year to $44 Million in Q1 2026 Expanding on the 2025 Full Year 700% Year-Over-Year Revenue Growth; Cash and Marketable Securities Total $381 Million • Q1 2026 Revenue Growth with Continued Strong Sales Momentum: $44.2 million, representing an ~168% year-over-year increase compared wit...
8-K Filing • SEC EDGAR
What's Driving IBRX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 7.69 for confirmation and 6.37 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 6.38 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
8.99
Invalidation
8.99
RSI(14)
47.2
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 6.38 and resistance at 7.69. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
IBRX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$7.8B
Company size
EV
$7.6B
Debt-adjusted value
P/E
-22.2
Not meaningful
P/S
55.3
Very high
P/B
-9.0
Not meaningful
EV/Sales
53.9
Very high
EV/EBIT
-29.1
Not meaningful
P/FCF
-26.1
Not meaningful
FCF Yield
-3.83%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Recovering
⚖
Balance Sheet
Manageable
💵 Revenue
44.21M
↗ Strong
📈 Net Income
-632.80M
↘ Negative
🧮 EPS (Basic)
-0.62
↘ Negative
IMMUNITYBIO, INC.
Healthcare • Biotech
Related Opportunities